Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Disparities in Representation of Women, Older Adults, and Racial/Ethnic Minorities in Immune Checkpoint Inhibitor Trials

The American Journal of Medicine(2022)10.1016/j.amjmed.2022.03.042Source: DataRank Database

Disparities in Representation of Women, Older Adults, and Racial/Ethnic Minorities in Immune Checkpoint Inhibitor Trials is a research paper published in The American Journal of Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 27 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

27 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (21 grants)Impact (FWCI 2.33)OA: closedTopics (39)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Mahnoor Islam,Ahsan Masood Khan ORCID,Syed Arsalan Ahmed Naqvi ORCID,Rabbia Siddiqi ORCID,Kaneez Zahra Rubab Khakwani

Live enrichment

PubMed:35483426 OpenAlex:https://openalex.org/W4224736666

National Institutes of Health

Grant: T15LM007092-30

NLM NIH HHS

Grant: T15 LM007092

AstraZeneca

Bristol-Myers Squibb

Merck

National Institute on Handicapped Research

Roche

Astellas Pharma US

Janssen Pharmaceuticals

Pfizer

Boehringer Ingelheim

ImmunoMedics

Sanofi

G1 Therapeutics

Exelixis

Gilead Sciences

American Association for Cancer Research

American Cancer Society

International Business Machines Corporation

Les Laboratories Pierre Fabre

Medical Research Council

FWCI

2.33

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

closedLicense: https://doi.org/10.15223/policy-004

publisherhttps://api.elsevier.com/content/article/PII:S000293432200328X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S000293432200328X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.amjmed.2022.03.042

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35483426

Fields of Study

Cancer Immunotherapy and BiomarkersEthics in Clinical ResearchCancer Genomics and DiagnosticsAgedEthnic and Racial MinoritiesEthnicityFemaleHispanic or LatinoHumansImmune Checkpoint InhibitorsMinority GroupsUnited States

MeSH Terms

Immune Checkpoint InhibitorsEthnic and Racial MinoritiesAgedEthnicityFemaleHispanic or LatinoHumansMinority GroupsUnited States

Keywords

MedicineDemographyEthnic groupConfidence intervalIncidence (geometry)Clinical trialPacific islandersSubgroup analysisPopulationInternal medicineGerontologyEnvironmental healthRACEWomenDisparitiesOlder AdultsImmune Checkpoint InhibitorsClinical Trial Enrolment

Sustainable Development Goals

SDG 0: Gender equality